Catalyst Phase
Accelerator Phase
Accelerator Awards are worth $185,000 to $1 million USD or more and are open to global Catalyst Award winners and finalists. These awards are intended for innovators who have demonstrated significant progress on their early-stage idea or project, preferably achieving proof of concept. Accelerator Award competitions are administered by sponsor organizations, each of which determines its respective eligibility criteria and selection process. Accelerator sponsors include Johnson and Johnson Innovation, Eisai Co., Ltd, the European Investment Bank, in partnership with kENUP Foundation, and Primetime Partners.
The Accelerator Phase began in 2021 and will continue through 2025.
Grand Prize Phase
The Grand Prize will serve as the capstone of the competition by rewarding the global Catalyst Award winner whose project is–or has the potential to be–most impactful in extending the human healthspan. The NAM will award one Grand Prize of $1.5 million in Q3 2026 and expects to open its application window in Q1 2026. The NAM will share further information with all global Catalyst Awardees during the latter half of 2025.